Drug Pricing in America: A Prescription for Change, Part I, Hearing Before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, First Session, January 29, 2019   [open pdf - 1006KB]

This is the January 29, 2019 hearing "Drug Pricing in America: A Prescription for Change, Part I," held before the Senate Committee on Finance. From the opening statement of Chuck Grassley: "Millions of Americans woke up this morning and started the day with their dose of prescription medications, including this Senator. For so many of our loved ones who have diabetes, high blood pressure, cystic fibrosis, epilepsy, and many other chronic health conditions, prescription drugs are a basic necessity of life. We need to continue to have a strong research engine to develop new treatments, but we must also have a discussion about the affordability of these drugs. Today you will hear many numbers describing the costs of those drugs. Those numbers are impressive, but the stories I have heard from patients, doctors, and pharmacists in Iowa have really gotten my attention. I have heard stories from doctors and pharmacists about skyrocketing prices of commonly used generic drugs." Statements, letters, and materials submitted for the record include those of the following: Kathy Sego, Douglas Holtz-Eakin, Mark Miller, and Peter Bach.

Report Number:
S. Hrg. 116-267; Senate Hearing 116-267
Public Domain
Retrieved From:
U.S. Government Publishing Office: http://www.gpo.gov/
Media Type:
Help with citations